Nkarta, Inc. (NKTX)
1.895
+0.02
(+1.34%)
USD |
NASDAQ |
Dec 12, 16:00
1.895
0.00 (0.00%)
After-Hours: 19:28
Nkarta Research and Development Expense (Annual): 87.59M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Biogen, Inc. | 1.755B |
| CEL-SCI Corp. | 18.16M |
| AIM ImmunoTech, Inc. | 6.149M |
| IGC Pharma, Inc. | 3.655M |
| NovaBay Pharmaceuticals, Inc. | 0.042M |